Physician profile
Omar Ahmed
NPI 1639312556
$906.43
in general payments reported to CMS, 2019-2025
18 companies · $17.38 in 2025
The $17.38 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $33.05 · 2021: $51.96 · 2022: $149 · 2023: $60.77 · 2025: $17.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $60.77 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $60.77 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.61 | 2019 | |
| Abbvie INC. | $128.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $108.49 | 2019-2023 | Tezspire |
| Glaxosmithkline, LLC. | $70.60 | 2019 | |
| Fisher & Paykel Healthcare INC | $62.56 | 2019 | |
| Pulmonx Corporation | $48.89 | 2022 | |
| Mallinckrodt Enterprises LLC | $46.66 | 2019 | |
| Inogen, INC. | $44.04 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Grifols USA, LLC | $43.58 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.52 | 2022 | |
| Boston Scientific Corporation | $37.67 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $33.62 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $23.68 | 2019 | |
| Electromed, INC. | $18.72 | 2019 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $15.01 | 2023 | Vapotherm |
| Genentech USA, INC. | $14.09 | 2019 | |
| Pfizer INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.